Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation

Circulation

Volumn 90, Issue 1, 1994, Pages 449-455

  Rakugi, Hiromi ^a   Wang, Dale S ^a   Dzau, Victor J ^a   Pratt, Richard E ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin; balloon; enzyme; renin; stenosis

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; QUINAPRIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD PRESSURE; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR SMOOTH MUSCLE;

EID: 0028272442     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.90.1.449     Document Type: Article

References (40)

1. Waller BF, Gorfinkel HJ, Rogers FJ, Kent KM, Roberts WC. Early and late morphologic changes in major epicardial coronary arteries after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1984;53:42C-47C.
2. Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty: potential biologic determinants and role of intimai hyperplasia. Circulation. 1989;79:1374-1387.
3. Powell JS, Glozel JP, Muller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245:186-188.
4. Osterrieder W, Müller RKM, Powell JS, Clozel JP, Hefti F, Baumgartner HR. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension. 1991;4(suppl II):II-60-II-64.
5. Farhy RD, Carretero OA, Ho KL, Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neomtimal proliferation. Circ Res. 1993;72:1202-1210.
6. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
7. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1419-1424.
8. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest. 1992;90:456-461.
9. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
10. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
11. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990; 86:1690-1697.
12. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest. 1994;93: 339-346.
13. MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation. 1992;86:100-110.
14. MARCATOR Investigators. Angiotensin converting enzyme inhibition and restenosis: the final results of the MARCATOR Trial. Circulation. 1992;86:I-53. Abstract.
15. Weishaar RE, Panek RL, Major TC, Simmerman J, Rapundalo ST, Taylor DG. Evidence for a functional tissue renin angiotensin system in the rat mesenteric vasculature and its involvement in regulating blood pressure. J Pharmacol Exp Ther. 1991;256: 568-574.
16. Kaplan HR, Taylor DG, Olson SC, Andrews LK. Quinapril: a preclinical review of the pharmacology, pharmacokinetics, and toxicology. Angiology. 1989;40(part 2):335-350.
17. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
18. Cheung HS, Cushman DW. Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca. Biochim Biophys Acta. 1973;293:451-463.
19. Kinoshita A, Urata H, Bumpus FM, Husain A. Measurement of angiotensin I converting enzyme inhibition in the heart. Circ Res. 1993;73:51-60.
20. Auerbach R, Alby L, Greives J, Joseph J, Lindgren C, Morrissey LW, Sidky YA, Tu M, Watt SL. Monoclonal antibody against angiotensin-converting enzyme: its use as a marker for murine, bovine, and human endothelial cells. Proc Natl Acad Sci USA. 1982;79:7891-7895.
21. Owens GK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension. 1987;9:178-187.
22. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.
23. Clozel J-P, Hess P, Michael C, Schietinger K, Baumgartner HR. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs. Hypertension. 1991; 18(suppl II):II-55-II-59.
24. Roux SP, Clozel J-P, Kuhn H. Cilazapril inhibits wall thickening of vein bypass graft in the rat. Hypertension. 1991;18(suppl II):II-43-II-46.
25. Chobanian AV. The effects of ACE inhibitors and other hypertensive drugs on cardiovascular risk factors and atherogenesis. Clin Cardiol. 1990;13:43-48.
26. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol. 1990;15(suppl 5): 556-572.
27. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension: effect of angiotensin converting enzyme inhibition. Hypertension. 1991;18:132-141.
28. Morishita R, Gibbons GH, Ellison KE, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Autocrine/paracrine renin angiotensin as a determinant of vascular structure: a gene transfer approach. Hypertension. 1993;22:445. Abstract.
29. Brenner BM, Troy JL, Bellerman BJ. Endothelium-dependent vascular responses: mediators and mechanisms. J Clin Invest. 1989; 84:1373-1378.
30. De Nucci G, Gryglewski RJ, Warner TD, Vane JR. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci. U S A. 1988;85:2334-2338.
31. deBlois D, Lombardi DM, Garvin MA, Schwartz SM. Inhibition by ramapril of intimal hyperplasia in the denuded rat carotid is reversed by HOE 140, a kinin B2 receptor antagonist. Circulation. 1992;86:I-226. Abstract.
32. Giachelli C, Majesky MW, Schwartz SM. Developmentally regulated cytochrome P-4501A1 expression in cultured rat vascular smooth muscle cells. J Biol Chem. 1991;266:3981-3986.
33. Majesky MW, Benditt EP, Schwartz SM. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1988;85:1524-1528.
34. Schwartz SM, Foy L, Bowen-Pope DR, Ross R. Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am J Pathol. 1990;136:1417-1428.
35. Rakugi H, Wang D, Giachelli C, Schwartz SM, Dzau VJ, Pratt RE. Developmentally regulated production of angiotensin converting enzyme in cultured rat vascular smooth muscle cells. Clin Res. 1992;40:146A.
36. Okamura T, Miyazcki M, Inagami T, Toda N. Vascular reninangiotensin system in two-kidney, one clip hypertensive rats. Hypertension. 1986;8:560-565.
37. Unger T, Ganten D, Lang RE, Scholkens VA. Is tissue converting inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with two different compounds: Hoe 398 and MD 421 in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1985;7:36-41.
38. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 1991;69:475-482.
39. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest. 1990;86:1913-1920.
40. Hanson SR, Powell JS, Dodson T, Lumsden A, Kelly AB, Anderson JS, Clowes AW, Harker LA. Effects of angiotensin converting enzyme inhibition with cilazapril on intimai hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension. 1991;18(suppl II):II-70-II-76.